IMVT Financial Statements

Balance sheet, income statement, cash flow, and dividends for Immunovant Inc (IMVT).


$4.69B Market Cap.

As of 05/29/2024 5:00 PM ET (MRY) • Disclaimer

IMVT Market Cap. (MRY)


IMVT Shares Outstanding (MRY)


IMVT Assets (MRY)


Total Assets

$666.37M

Total Liabilities

$48.61M

Total Investments

$0

IMVT Income (MRY)


Revenue

$0

Net Income

-$259.34M

Operating Expense

$282.71M

IMVT Cash Flow (MRY)


CF Operations

-$214.23M

CF Investing

-$360.00K

CF Financing

$472.43M

IMVT Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

IMVT Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$666,365,000 (64.19%)

$405,838,000 (-21.28%)

$515,564,000 (24.99%)

$412,489,000 (277.09%)

Assets Current

$665,770,000 (64.66%)

$404,333,000 (-21.17%)

$512,931,000 (25.41%)

$409,006,000 (274.97%)

Assets Non-Current

$595,000 (-60.47%)

$1,505,000 (-42.84%)

$2,633,000 (-24.40%)

$3,483,000 (1019.94%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

$617,757,000 (70.42%)

$362,494,000 (-22.84%)

$469,825,000 (20.01%)

$391,480,000 (316.16%)

Property Plant & Equipment Net

$595,000 (-60.47%)

$1,505,000 (-42.84%)

$2,633,000 (-24.40%)

$3,483,000 (5258.46%)

Cash & Equivalents

$635,365,000 (68.74%)

$376,532,000 (-23.75%)

$493,817,000 (23.41%)

$400,146,000 (297.87%)

Accumulated Other Comprehensive Income

$1,908,000 (123.94%)

$852,000 (110.89%)

$404,000 (235.57%)

-$298,000 (-1762.50%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$5,337,000 (662.43%)

$700,000 (-94.28%)

$12,229,000 (1951.85%)

$596,000 (0%)

Trade & Non-Trade Payables

$7,170,000 (429.93%)

$1,353,000 (-92.80%)

$18,800,000 (673.03%)

$2,432,000 (-44.47%)

Accumulated Retained Earnings (Deficit)

-$825,683,000 (-45.79%)

-$566,347,000 (-59.36%)

-$355,387,000 (-78.89%)

-$198,657,000 (-117.76%)

Tax Assets

$166,000 (0%)

$0 (0%)

$632,000 (15.33%)

$548,000 (-82.00%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$138,000 (-88.69%)

$1,220,000 (-48.39%)

$2,364,000 (-30.82%)

$3,417,000 (0%)

Debt Current

$138,000 (-88.24%)

$1,173,000 (2.45%)

$1,145,000 (-2.88%)

$1,179,000 (0%)

Debt Non-Current

$0 (0%)

$47,000 (-96.14%)

$1,219,000 (-45.53%)

$2,238,000 (0%)

Total Liabilities

$48,608,000 (12.14%)

$43,344,000 (-5.24%)

$45,739,000 (117.71%)

$21,009,000 (37.15%)

Liabilities Current

$48,608,000 (12.27%)

$43,297,000 (-2.75%)

$44,520,000 (137.17%)

$18,771,000 (22.54%)

Liabilities Non-Current

$0 (0%)

$47,000 (-96.14%)

$1,219,000 (-45.53%)

$2,238,000 (0%)

IMVT Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$57,281,000 (19.29%)

$48,019,000 (-11.44%)

$54,225,000 (37.23%)

$39,513,000 (117.69%)

Research & Development Expense

$212,928,000 (32.87%)

$160,257,000 (57.41%)

$101,808,000 (48.40%)

$68,604,000 (43.14%)

Operating Expenses

$282,709,000 (29.37%)

$218,529,000 (39.36%)

$156,814,000 (45.04%)

$108,117,000 (63.62%)

Interest Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Income Tax Expense

$567,000 (6200.00%)

$9,000 (110.71%)

-$84,000 (76.54%)

-$358,000 (-469.07%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$259,336,000 (-22.93%)

-$210,960,000 (-34.60%)

-$156,730,000 (-45.89%)

-$107,431,000 (-61.82%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$259,336,000 (-22.93%)

-$210,960,000 (-34.60%)

-$156,730,000 (-45.89%)

-$107,431,000 (-61.82%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$259,336,000 (-22.93%)

-$210,960,000 (-34.60%)

-$156,730,000 (-45.89%)

-$107,431,000 (-61.82%)

Weighted Average Shares

$138,100,577 (12.21%)

$123,075,329 (12.21%)

$109,679,256 (24.98%)

$87,756,513 (103.14%)

Weighted Average Shares Diluted

$138,100,577 (12.21%)

$123,075,329 (12.21%)

$109,679,256 (24.98%)

$87,756,513 (103.14%)

Earning Before Interest & Taxes (EBIT)

-$258,769,000 (-22.67%)

-$210,951,000 (-34.52%)

-$156,814,000 (-45.48%)

-$107,789,000 (-64.15%)

Gross Profit

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Operating Income

-$282,709,000 (-29.37%)

-$218,529,000 (-39.36%)

-$156,814,000 (-45.04%)

-$108,117,000 (-63.62%)

IMVT Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$360,000 (-82.74%)

-$197,000 (22.44%)

-$254,000 (-20.95%)

-$210,000 (-577.42%)

Net Cash Flow from Financing

$472,427,000 (566.47%)

$70,885,000 (-64.58%)

$200,129,000 (-47.76%)

$383,112,000 (160.67%)

Net Cash Flow from Operations

-$214,227,000 (-13.83%)

-$188,193,000 (-77.35%)

-$106,112,000 (-27.34%)

-$83,327,000 (-56.17%)

Net Cash Flow / Change in Cash & Cash Equivalents

$258,833,000 (320.69%)

-$117,285,000 (-225.21%)

$93,671,000 (-68.73%)

$299,575,000 (220.11%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$360,000 (-82.74%)

-$197,000 (22.44%)

-$254,000 (-20.95%)

-$210,000 (-577.42%)

Issuance (Repayment) of Debt Securities

$0 (0%)

$0 (0%)

$0 (0%)

-$3,190,000 (-108.42%)

Issuance (Purchase) of Equity Shares

$478,439,000 (572.37%)

$71,157,000 (55060.47%)

$129,000 (-99.97%)

$387,538,000 (33366.15%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$993,000 (351.36%)

$220,000 (339.13%)

-$92,000 (0%)

$0 (0%)

Share Based Compensation

$41,116,000 (27.31%)

$32,296,000 (-5.69%)

$34,244,000 (81.94%)

$18,822,000 (170.31%)

Depreciation Amortization & Accretion

$1,361,000 (2.79%)

$1,324,000 (7.47%)

$1,232,000 (23.45%)

$998,000 (4652.38%)

IMVT Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

-

-

-

-

Profit Margin

-

-

-

-

EBITDA Margin

-

-

-

-

Return on Average Equity (ROAE)

-56.10% (-7.06%)

-52.40% (-56.89%)

-33.40% (-17.61%)

-28.40% (76.91%)

Return on Average Assets (ROAA)

-51.30% (-6.21%)

-48.30% (-55.31%)

-31.10% (-15.19%)

-27.00% (52.13%)

Return on Sales (ROS)

-

-

-

-

Return on Invested Capital (ROIC)

1372.10% (-60.64%)

3486.10% (254.78%)

982.60% (-77.42%)

4351.20% (3628.95%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-17.19 (-89.48%)

-9.07 (-135.40%)

-3.85 (70.70%)

-13.15 (-30.09%)

Price to Sales Ratio (P/S)

-

-

-

-

Price to Book Ratio (P/B)

7.6 (36.35%)

5.57 (308.28%)

1.36 (-65.99%)

4.01 (-57.03%)

Debt to Equity Ratio (D/E)

0.08 (-34.17%)

0.12 (23.71%)

0.1 (79.63%)

0.05 (-66.87%)

Earnings Per Share (EPS)

-1.88 (-9.94%)

-1.71 (-19.58%)

-1.43 (-17.21%)

-1.22 (20.78%)

Sales Per Share (SPS)

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Free Cash Flow Per Share (FCFPS)

-1.55 (-1.50%)

-1.53 (-57.84%)

-0.97 (-1.89%)

-0.95 (22.98%)

Book Value Per Share (BVPS)

4.47 (51.88%)

2.94 (-31.26%)

4.28 (-3.97%)

4.46 (104.82%)

Tangible Assets Book Value Per Share (TABVPS)

4.83 (46.35%)

3.3 (-29.87%)

4.7 (0.02%)

4.7 (85.62%)

Enterprise Value Over EBIT (EV/EBIT)

-15 (-87.50%)

-8 (-700.00%)

-1 (90.91%)

-11 (8.33%)

Enterprise Value Over EBITDA (EV/EBITDA)

-15.55 (-105.20%)

-7.58 (-906.64%)

-0.75 (93.03%)

-10.8 (6.15%)

Asset Turnover

0 (0%)

0 (0%)

0 (0%)

0 (0%)

Current Ratio

13.7 (46.66%)

9.34 (-18.94%)

11.52 (-47.12%)

21.79 (205.98%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$214,587,000 (-13.91%)

-$188,390,000 (-77.11%)

-$106,366,000 (-27.33%)

-$83,537,000 (-56.47%)

Enterprise Value (EV)

$4,003,784,861 (151.97%)

$1,589,008,146 (1257.01%)

$117,096,456 (-89.84%)

$1,152,980,738 (52.67%)

Earnings Before Tax (EBT)

-$258,769,000 (-22.67%)

-$210,951,000 (-34.52%)

-$156,814,000 (-45.48%)

-$107,789,000 (-62.60%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$257,408,000 (-22.79%)

-$209,627,000 (-34.74%)

-$155,582,000 (-45.69%)

-$106,791,000 (-62.68%)

Invested Capital

-$17,470,000 (-36.79%)

-$12,771,000 (37.42%)

-$20,409,000 (-577.81%)

-$3,011,000 (53.69%)

Working Capital

$617,162,000 (70.94%)

$361,036,000 (-22.92%)

$468,411,000 (20.03%)

$390,235,000 (316.22%)

Tangible Asset Value

$666,365,000 (64.19%)

$405,838,000 (-21.28%)

$515,564,000 (24.99%)

$412,489,000 (277.09%)

Market Capitalization

$4,694,415,861 (132.38%)

$2,020,105,146 (214.98%)

$641,340,456 (-59.19%)

$1,571,458,738 (78.83%)

Average Equity

$462,194,250 (14.87%)

$402,353,250 (-14.25%)

$469,225,500 (24.15%)

$377,953,250 (600.13%)

Average Assets

$505,275,750 (15.57%)

$437,220,750 (-13.14%)

$503,376,250 (26.66%)

$397,426,000 (237.37%)

Invested Capital Average

-$18,859,000 (-211.65%)

-$6,051,250 (62.08%)

-$15,959,500 (-544.24%)

-$2,477,250 (-104.65%)

Shares

145,292,970 (11.55%)

130,245,335 (11.90%)

116,395,727 (18.81%)

97,971,243 (73.54%)